Literature DB >> 22833265

Frizzled homolog proteins, microRNAs and Wnt signaling in cancer.

Koji Ueno1, Hiroshi Hirata, Yuji Hinoda, Rajvir Dahiya.   

Abstract

Wnt signaling pathways play important roles in tumorigenesis and are initiated by binding of Wnt to various receptors including frizzleds (FZDs). FZDs are one of several families of receptors comprised of FZD/LRP/ROR2/RYK in the Wnt signaling pathway. Expression of some FZD receptors are up regulated, thereby activating the Wnt signaling pathway and is correlated with cancer malignancy and patient outcomes (recurrence and survival) in many cancers. The FZD family contains ten genes in humans and their function has not been completely examined including the regulatory mechanisms of FZD genes in cancer. Knockdown of FZDs may suppress the Wnt signaling pathway resulting in decreased cell growth, invasion, motility and metastasis of cancer cells. Recently a number of microRNAs (miRNAs) have been identified and reported to be important in several cancers. MiRNAs regulate target gene expression at both the transcription and translation levels. The study of miRNA is a newly emerging field and promises to be helpful in understanding the pathogenesis of FZDs in cancer. In addition, miRNAs may be useful in regulating FZDs in cancer cells. Therefore, the aim of this review is to discuss current knowledge of the functional mechanisms of FZDs in cancer, including regulation by miRNAs and the potential for possible use of miRNAs and FZDs in future clinical applications.
Copyright © 2012 UICC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22833265      PMCID: PMC3940357          DOI: 10.1002/ijc.27746

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  158 in total

1.  Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling.

Authors:  M Enomoto; S Hayakawa; S Itsukushima; D Y Ren; M Matsuo; K Tamada; C Oneyama; M Okada; T Takumi; M Nishita; Y Minami
Journal:  Oncogene       Date:  2009-06-29       Impact factor: 9.867

2.  Genetic aberrations in prostate cancer by microarray analysis.

Authors:  Outi R Saramäki; Kati P Porkka; Robert L Vessella; Tapio Visakorpi
Journal:  Int J Cancer       Date:  2006-09-15       Impact factor: 7.396

3.  Molecular cloning of Frizzled-10, a novel member of the Frizzled gene family.

Authors:  J Koike; A Takagi; T Miwa; M Hirai; M Terada; M Katoh
Journal:  Biochem Biophys Res Commun       Date:  1999-08-19       Impact factor: 3.575

4.  LRP6 expression promotes cancer cell proliferation and tumorigenesis by altering beta-catenin subcellular distribution.

Authors:  Yonghe Li; Wenyan Lu; Xi He; Alan L Schwartz; Guojun Bu
Journal:  Oncogene       Date:  2004-12-02       Impact factor: 9.867

5.  Wnt isoform-specific interactions with coreceptor specify inhibition or potentiation of signaling by LRP6 antibodies.

Authors:  Yan Gong; Eric Bourhis; Cecilia Chiu; Scott Stawicki; Venita I DeAlmeida; Bob Y Liu; Khanhky Phamluong; Tim C Cao; Richard A D Carano; James A Ernst; Mark Solloway; Bonnee Rubinfeld; Rami N Hannoush; Yan Wu; Paul Polakis; Mike Costa
Journal:  PLoS One       Date:  2010-09-13       Impact factor: 3.240

6.  Wnt signalling in adenomas of familial adenomatous polyposis patients.

Authors:  G M Caldwell; C E Jones; A M Ashley; W Wei; R K Hejmadi; D G Morton; G M Matthews
Journal:  Br J Cancer       Date:  2010-07-13       Impact factor: 7.640

Review 7.  WNT and beta-catenin signalling: diseases and therapies.

Authors:  Randall T Moon; Aimee D Kohn; Giancarlo V De Ferrari; Ajamete Kaykas
Journal:  Nat Rev Genet       Date:  2004-09       Impact factor: 53.242

8.  Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma.

Authors:  Henry F Frierson; Adel K El-Naggar; John B Welsh; Lisa M Sapinoso; Andrew I Su; Jun Cheng; Takashi Saku; Christopher A Moskaluk; Garret M Hampton
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

Review 9.  The Frizzled family: receptors for multiple signal transduction pathways.

Authors:  Hui-Chuan Huang; Peter S Klein
Journal:  Genome Biol       Date:  2004-06-14       Impact factor: 13.583

10.  The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma.

Authors:  M P O'Connell; J L Fiori; M Xu; A D Carter; B P Frank; T C Camilli; A D French; S K Dissanayake; F E Indig; M Bernier; D D Taub; S M Hewitt; A T Weeraratna
Journal:  Oncogene       Date:  2009-10-05       Impact factor: 9.867

View more
  40 in total

1.  Intranasal wnt3a Attenuates Neuronal Apoptosis through Frz1/PIWIL1a/FOXM1 Pathway in MCAO Rats.

Authors:  Nathanael Matei; Justin Camara; Devin McBride; Richard Camara; Ningbo Xu; Jiping Tang; John H Zhang
Journal:  J Neurosci       Date:  2018-06-28       Impact factor: 6.167

Review 2.  MicroRNAs in the Migration of Mesenchymal Stem Cells.

Authors:  Lihong He; Huanxiang Zhang
Journal:  Stem Cell Rev Rep       Date:  2019-02       Impact factor: 5.739

Review 3.  Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer.

Authors:  Nijiro Nohata; Yusuke Goto; J Silvio Gutkind
Journal:  J Hum Genet       Date:  2016-10-13       Impact factor: 3.172

Review 4.  Role of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature review.

Authors:  Miguel Angel Chiurillo
Journal:  World J Exp Med       Date:  2015-05-20

5.  Structural and dynamic characterization of human Wnt2-Fzd7 complex using computational approaches.

Authors:  Hourieh Kalhor; Mansour Poorebrahim; Hamzeh Rahimi; Ali Akbar Shabani; Morteza Karimipoor; Mohammad Reza Akbari Eidgahi; Ladan Teimoori-Toolabi
Journal:  J Mol Model       Date:  2018-09-06       Impact factor: 1.810

6.  Genomic Correlates of Exceptional Response to ErbB3 Inhibition in Head and Neck Squamous Cell Carcinoma.

Authors:  Daniel L Faden; Roberto Gomez-Casal; Diego Alvarado; Umamaheswar Duvvuri
Journal:  JCO Precis Oncol       Date:  2019-03-25

7.  MicroRNA-206 attenuates glioma cell proliferation, migration, and invasion by blocking the WNT/β-catenin pathway via direct targeting of Frizzled 7 mRNA.

Authors:  Fengqi Zhou; Wenping Cao; Ran Xu; Junxia Zhang; Tianfu Yu; Xiupeng Xu; Tongle Zhi; Jianxing Yin; Shengwu Cao; Ning Liu; Yingyi Wang; Chunsheng Zhao
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

8.  MicroRNA-184 modulates canonical Wnt signaling through the regulation of frizzled-7 expression in the retina with ischemia-induced neovascularization.

Authors:  Yusuke Takahashi; Qian Chen; Raju V S Rajala; Jian-Xing Ma
Journal:  FEBS Lett       Date:  2015-03-18       Impact factor: 4.124

Review 9.  Targeting the Wnt pathway in human cancers: therapeutic targeting with a focus on OMP-54F28.

Authors:  Phuong N Le; Jessica D McDermott; Antonio Jimeno
Journal:  Pharmacol Ther       Date:  2014-08-27       Impact factor: 12.310

10.  DLK1: a novel target for immunotherapeutic remodeling of the tumor blood vasculature.

Authors:  Nina Chi Sabins; Jennifer L Taylor; Kellsye P L Fabian; Leonard J Appleman; Jodi K Maranchie; Donna Beer Stolz; Walter J Storkus
Journal:  Mol Ther       Date:  2013-07-30       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.